Meeting
2020 ASCO Virtual Scientific Program
A urine exosomal circRNA classifier for detection of high-grade prostate cancer at initial biopsy: A multicenter, retrospective study.
Authors
Liaoyuan Li
Sun Yat-sen University, Guangzhou, China
Liaoyuan Li , Wen Tao , Yadi He , Tao He , Qing Li , Zhenquan Wu , Weiming Deng , Lingxiao Zhang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Biologic Correlates
Citation
J Clin Oncol 38: 2020 (suppl; abstr 5522)
DOI
10.1200/JCO.2020.38.15_suppl.5522
Abstract #
5522
Poster Bd #
103
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Interim performance of a non-DRE urine exosome gene signature to predict Gleason ≥7 prostate cancer on initial prostate needle biopsy from patients enrolled in a prospective observational trial.
First Author: Michael J. Donovan
Poster
2023 ASCO Annual Meeting
Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.
First Author: Neha Vapiwala
Poster
2023 ASCO Genitourinary Cancers Symposium
Phase III study of local or systemic therapy intensification directed by PET in prostate cancer patients with post-prostatectomy biochemical recurrence (INDICATE): ECOG-ACRIN EA8191.
First Author: Neha Vapiwala
Poster
2018 Genitourinary Cancers Symposium
Phase II randomized study of abiraterone acetate plus ADT versus apalutamide versus abiraterone and apalutamide in patients with advanced prostate cancer with non-castrate testosterone levels. (LACOG 0415).
First Author: Fernando C. Maluf